by © Marcos del Mazo | Dreamstime.com Swissmedic, Switzerland’s drug approval agency, extended approval of the Moderna Covid-19 vaccine for use on 12 to 17 year olds this week. On 9 August 2021, Swissmedic said that it had carefully examined an application from Moderna Switzerland and had decided to extend the temporary authorisation for the use ...
Topics:
Investec considers the following as important: 3) Swiss Markets and News, 3a) Health, Coronavirus Switzerland, Covid-19 Switzerland, Editor's Choice, Featured, health, newsletter
This could be interesting, too:
Guillermo Alcala writes USD/CHF slides to test 0.8645 support with US inflation data on tap
Swissinfo writes Swiss central bank posts CHF62.5bn profit
Nachrichten Ticker - www.finanzen.ch writes Trump-Faktor und Marktbedingungen könnten für neuen Bitcoin-Rekord sorgen
Charles Hugh Smith writes Is Social Media Actually “Media,” Or Is It Something Else?
© Marcos del Mazo | Dreamstime.com
Swissmedic, Switzerland’s drug approval agency, extended approval of the Moderna Covid-19 vaccine for use on 12 to 17 year olds this week.
On 9 August 2021, Swissmedic said that it had carefully examined an application from Moderna Switzerland and had decided to extend the temporary authorisation for the use of its Spikevax vaccine on 12 to 17 year olds.
The application, which included data on 3,732 vaccinated children aged between 12 and 17, was submitted on 11 June 2021. Those included in the study received the same dose as adults and had a similar immune response to adults aged 18 to 25.
The side effects most frequently experienced by the children aged 12 to 17 in the study were similar to those aged 18 and over. In the clinical trial, the vaccine showed an efficacy against symptomatic disease (at least one symptom and positive PCR test) of about 93% 14 days after the second dose. Side effects usually lasted between one and three days, and were typically more pronounced after the second dose.
Previously, the only vaccine authorised for use on adolescents in Switzerland was the Pfizer/BioNTech vaccine, which had its temporary approval extended to 12 to 15 year olds on 4 June 2021.
More on this:
Swissmedic press release (in French) – Take a 5 minute French test now
For more stories like this on Switzerland follow us on Facebook and Twitter.
You Might Also Like
SNB Sight Deposits: Inflation is there, CHF must Rise
2021-08-16
Sight Deposits have risen by +2.7 bn CHF, this means that the SNB is intervening and buying Euros and Dollars.
Unvaccinated 80 times more likely to catch Covid-19, finds Swiss study
2021-08-08
Recent analysis of data done in the Swiss canton of Vaud found rate of Covid-19 was 83 times higher among the unvaccinated than those who had received two shots of vaccine, reported RTS.
Switzerland to open mass events and nightclubs to those with Covid certificates
2021-06-26
On 23 June 2021, Switzerland’s government announced that it was loosening a wide range of Covid-19 restrictions from Saturday. From Saturday, 26 June 2021 rules on nightclubs, large events, remote working, education and restaurants will be loosened. In addition, it will become easier for travelers to enter Switzerland.
Covid: UK now on Swiss risk list
2021-05-28
On 27 May 2021, the UK was added Switzerland’s list of risk countries. This means that anyone arriving in Switzerland from the UK from 6pm on Thursday must quarantine upon arrival, with a few exceptions. The UK was added to the Federal Office of Public Health’s (FOPH) list of countries with a worrying variant, alongside Brazil, Canada, India, Nepal and South Africa.
Covid: vaccination of 12 to 15 year olds on the horizon in Switzerland
2021-05-14
Those with teenagers wishing for the greater travel freedom likely to come with proof of vaccination may have cause for hope. On 7 May 2021, Pfizer submitted an authorisation application to Swissmedic, Switzerland’s drug approval agency, for use of its vaccine against Covid-19 on those aged 12 to 15 years old.
Covid: new cases trend down with vaccine progress
2021-05-07
This week, saw 10,639 new Covid-19 cases in Switzerland, down 21% from a week before (13,465) continuing the slow down in growth of new numbers experienced last week (-5%). The 7-day average is currently 1,519.
Covid: the 3 phases of Switzerland’s return to normal
2021-04-24
This week, Switzerland’s government set out the three phases of its plan to return to normal at a press conference recorded by RTS. The first is the protection phase, which we are currently in. This involves vaccinating the vulnerable and could last until the end of May 2021.
France asks Switzerland for help with Covid patients
2021-04-09
The French region of Bourgogne-Franche Comté has contacted several Swiss cantons and asked them if they would take Covid patients, according to RTS. Jacques Gerber, the minister of health in the canton of Jura told RTS that there had been a request from France to prepare in case French hospitals become overloaded.
Tags: Coronavirus Switzerland,Covid-19 Switzerland,Editor's Choice,Featured,Health,newsletter